These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8745328)

  • 1. Cultured skin as a 'smart material' for healing wounds: experience in venous ulcers.
    Sabolinski ML; Alvarez O; Auletta M; Mulder G; Parenteau NL
    Biomaterials; 1996 Feb; 17(3):311-20. PubMed ID: 8745328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue engineering in wound repair.
    Falanga VJ
    Adv Skin Wound Care; 2000; 13(2 Suppl):15-9. PubMed ID: 11074998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing.
    Brem H; Balledux J; Bloom T; Kerstein MD; Hollier L
    Arch Surg; 2000 Jun; 135(6):627-34. PubMed ID: 10843357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cultured allogeneic skin cells are effective in the treatment of chronic diabetic leg and foot ulcers.
    Harvima IT; Virnes S; Kauppinen L; Huttunen M; Kivinen P; Niskanen L; Horsmanheimo M
    Acta Derm Venereol; 1999 May; 79(3):217-20. PubMed ID: 10384921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovative therapies in wound healing.
    Shen JT; Falanga V
    J Cutan Med Surg; 2003; 7(3):217-24. PubMed ID: 12704530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers.
    Falanga V; Sabolinski M
    Wound Repair Regen; 1999; 7(4):201-7. PubMed ID: 10781211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group.
    Falanga V; Margolis D; Alvarez O; Auletta M; Maggiacomo F; Altman M; Jensen J; Sabolinski M; Hardin-Young J
    Arch Dermatol; 1998 Mar; 134(3):293-300. PubMed ID: 9521027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective comparison of diabetic foot ulcer and venous stasis ulcer healing outcome between a dermal repair scaffold (PriMatrix) and a bilayered living cell therapy (Apligraf).
    Karr JC
    Adv Skin Wound Care; 2011 Mar; 24(3):119-25. PubMed ID: 21326023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
    Curran MP; Plosker GL
    BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the efficacies of alginate, foam, hydrocolloid, hydrofiber, and hydrogel dressings in the management of diabetic foot ulcers and venous leg ulcers: a systematic review and meta-analysis examining how to dress for success.
    Saco M; Howe N; Nathoo R; Cherpelis B
    Dermatol Online J; 2016 Aug; 22(8):. PubMed ID: 27617934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mantova cell factory: a model for skin regeneration].
    Negri S; Gasparato N; Fila C; Danese N; Farinato S; Bottoli C; Bellomi A
    G Ital Nefrol; 2009; 26 Suppl 45():S69-73. PubMed ID: 19382098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds.
    Loots MA; Lamme EN; Zeegelaar J; Mekkes JR; Bos JD; Middelkoop E
    J Invest Dermatol; 1998 Nov; 111(5):850-7. PubMed ID: 9804349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wound care in venous ulcers.
    Mosti G
    Phlebology; 2013 Mar; 28 Suppl 1():79-85. PubMed ID: 23482540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reality of routine practice: a pooled data analysis on chronic wounds treated with TLC-NOSF wound dressings.
    Münter KC; Meaume S; Augustin M; Senet P; Kérihuel JC
    J Wound Care; 2017 Feb; 26(Sup2):S4-S15. PubMed ID: 28182533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spray-applied cell therapy with human allogeneic fibroblasts and keratinocytes for the treatment of chronic venous leg ulcers: a phase 2, multicentre, double-blind, randomised, placebo-controlled trial.
    Kirsner RS; Marston WA; Snyder RJ; Lee TD; Cargill DI; Slade HB
    Lancet; 2012 Sep; 380(9846):977-85. PubMed ID: 22863328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Single-center, Retrospective Study of Cryopreserved Umbilical Cord for Wound Healing in Patients Suffering From Chronic Wounds of the Foot and Ankle.
    Couture M
    Wounds; 2016 Jul; 28(7):217-25. PubMed ID: 27428716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The non-healing wound].
    Pfeffer F; von Dobschuetz E; Riediger H; Moosmann C; Hopt UT
    MMW Fortschr Med; 2004 Oct; 146(44):45-8. PubMed ID: 15566249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial.
    Veves A; Falanga V; Armstrong DG; Sabolinski ML;
    Diabetes Care; 2001 Feb; 24(2):290-5. PubMed ID: 11213881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of bioengineered skin substitutes on diabetic foot ulcer and venous leg ulcer outcomes.
    Barber C; Watt A; Pham C; Humphreys K; Penington A; Mutimer K; Edwards M; Maddern G
    J Wound Care; 2008 Dec; 17(12):517-27. PubMed ID: 19052516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy and mechanism of bilayered living human skin equivalent (HSE) in treatment of diabetic foot ulcers.
    Brem H; Young J; Tomic-Canic M; Isaacs C; Ehrlich HP
    Surg Technol Int; 2003; 11():23-31. PubMed ID: 12931279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.